Image by Tonyç via Flickr
So, why do some continue to fool around with IR [Immediate Release] meds? – Money talks, insurance money.
Looks like blue sky thinking to me…
Managed Care Creates A Significant Problem, Cost is a Problem, but IR medications then create even greater downstream challenges that often lead to treatment failure and non-compliance: Many fail because they don't take the medications consistently.
See the 7 Tips on how to better understand IR titration strategies, soon at EzineArticles.com
With
the increased influence of managed care, the choices of medications for
thousands are limited to the generic [often less expensive] immediate
release medications. IR medications are less than satisfactory in the
first place, for reasons listed in the 7 Tips Article.
Ineffective treatment
incurs greater long-term costs on many levels. Why managed care would
encourage the use of less medically effective products and create
greater cost, coupled with that inferior patient care, is a challenging
subject beyond the scope of this brief overview.
Clinical Implications of IR Medications
On
first thought, one might guess that the IR medications would almost
always be adjusted correctly, as they have been around for decades, and
appear at first as more simple, less complex intervention strategies. The uniformed hope for that conclusion, partly because it appears to make common sense.
The
most difficult aspect of this unhappy circumstance: IR choices with
stimulant medications regularly seem to invite insufficient attention
to adequate adjustment. Indeed they are often adjusted incorrectly. When the DOE for the day is not covered, the patient does not focus, cannot meet responsibilities sufficiently.
Watch for this upcoming article – should be approved soon at Ezines, …isn't Grumpy, but applies to many folks using the IR dosing strategies for stimulant meds.
Make sure you take a look at these pages!
ADHD Medication Rules Purchase
“Rules” Affiliate Link
Neuroscience Details
If you found this article interesting please SHARE it:
![]()
{ 4 comments }
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_c.png?x-id=edb94f59-3fca-4223-9aa1-d675473207bf)






